Witchuda Sukjoi

Dr. Witchuda Sukjoi


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2026 in Cosmetics
Verified
Journal Article
Open access
PDF file
Oraphan AnurukvorakunOraphan Anurukvorakun
Oraphan Anurukvorakun
WSWitchuda Sukjoi
Witchuda Sukjoi
JCJaroenporn Chokboribal
Jaroenporn Chokboribal
This study optimized a Thai herbal blend inhibiting tyrosinase and evaluated its delivery in niosomal serum versus a corresponding non-niosomal (free extract) serum. The physicochemical properties, antioxidant and tyrosinase-inhibitory activities, stability, and clinical effects of the two serums were assessed in an 8-week study in healthy volunteers. Herbal combinations were screened using a two-level, five-factor design with tyrosinase inhibition as the response, and the optimized extract ratio (3:2:3:2:2, w/w) was incorporated into conventional, liposomal, and niosomal formulations. Vesicle characterization and in vitro performance supported the niosomal serum for clinical comparison with the corresponding non-niosomal product. The niosomal serum showed appreciable DPPH radical-scavenging activity (IC50 32 mg/mL), whereas the conventional serum exhibited the highest tyrosinase inhibition (IC50 8.3 mg/mL). Clinically, 30 of 50 randomized volunteers completed the 8-week trial and were included in the efficacy analysis. The niosomal serum produced more consistent improvements in skin hydration and transepidermal water loss, with significant benefits over the non-niosomal (free extract) serum at selected mid-to-late time points. Erythema decreased significantly with both formulations, whereas melanin reduction was modest. These findings support the use of niosomal formulations containing combined Thai herbal extracts as a practical strategy to enhance moisturization and barrier support in skincare formulations.

20 May 2026 in Cosmetics
Verified
Journal Article
Open access
PDF file
SCSirinda Chalermthiralert
Sirinda Chalermthiralert
WSWitchuda Sukjoi
Witchuda Sukjoi
STSutatip Thonglem
Sutatip Thonglem
Narongrit LahpunNarongrit Lahpun
Narongrit Lahpun
The demand for eco-friendly photoprotection has increased due to the observed adverse effects of conventional UV filters on marine ecosystems. In this study, we developed a broad-spectrum, reef-friendly sunscreen emulsion containing Perilla frutescens seed extract. The extraction process was optimized using 95% ethanol maceration for one week, yielding the highest SPF of 22.61. Gas chromatography–mass spectrometry (GC-MS/MS) was used to identify linolenic acid (43.54%) as the predominant fatty acid. Cytotoxicity test results for HaCaT keratinocytes were used to confirm the extract’s safety, with an IC50 of 12.9 mg/mL. The formulated sunscreen met environmental safety standards based on persistence, bioaccumulation, and toxicity (PBT) criteria. A clinical safety evaluation using a 24 h closed patch test (n = 17) demonstrated that the formulation induced no significant alterations in TEWL or erythema levels (p > 0.05), confirming its dermatological safety. In a clinical efficacy evaluation involving 30 volunteers, the formulation containing 1% perilla extract reduced both erythema values and the melanin index, with no statistically significant difference observed (p > 0.05). These findings demonstrate that P. frutescens seed extract is a potent bioactive ingredient for sustainable cosmeceuticals, offering effective sun protection while ensuring safety for both human skin and marine environments.